FDA Investigator Rebeca M Melendez
Rebeca M Melendez has inspections in 1 countries as of 28 Mar 2023. Rebeca M Melendez has collaborated with a combinined 1276 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
8
Last Inspection Date:
28 Mar 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Abigail A Auster,
Adalberto Cajigas,
Adaliz Santaliz Cruz,
Alan A Rivera,
Angelica M Hernandez,
Ann L Demarco,
Annette Melendez,
Ariel Cruz Figueroa,
Arlene M Badillo,
Arwa S El Hagrasy,
Binh T Nguyen,
Brenda Rivera,
Brian J Ryan,
Carlos A Medina,
Christina Capacci Daniel, PhD,
Dayna I Martinez,
Dennis Cantellops Paite,
Donna Christner,
Edwin Martinez,
German Rivera,
Iraida Ortiz,
Ivis L Negron,
Ivis Lnegron Torres,
Javier O Vega,
Jorge L Gonzalez,
Jorge L Guadalupe,
Jose A Cruz,
Jose A Moreno,
Jose Acruz Gonzalez,
Jose Alopez Rubet,
José E Meléndez,
Jose E Melendez, DDC,
Jose F Pedro,
Jose F Pedró,
Jose Fpedrode Jesus,
Jose Lpez,
Jose Martinez, Jr,
Jose Melendez,
Jose R Lopez,
Jose Velez,
Juan Rjimenez Garcia,
Laura E Garcia,
Laurimer Kuilan Torres,
Libia M Lugo,
Lisa M Lopez,
Lourdes Andujar,
Marian E Ramirez,
Michelle Y Clark Stuart,
Miguel A Martinez,
Miguel Hernandez Sanchez,
Min Tang,
Muralidhara B Gavini, PhD,
Myriam M Sosa,
Noreen Muniz,
Noreen Muñiz,
Pablo Feliciano,
Rafael E Cruz,
Rafael Nevarez,
Rafael Nevarez Nieves,
Ramon A Hernandez,
Raquel Gonzalez,
Raquel Gonzalez Rivera,
Rebecca Parrilla,
Rebecca Rodriguez,
Regina T Brown,
Sharmista Chatterjee,
Sixto M Mercado Rios,
Steven B Barber,
Thomas J Arista,
Vilmary Negron Rodriguez,
Wanda J Torres
Rebeca M Melendez's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2003 | EIR | Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - EIR, 2003-03-13 |
June, 2006 | FDA 483 | Ivax Pharmaceuticals, Inc. - Form 483, 2006-06-02 |
June, 2006 | EIR | Janssen Ortho LLC - EIR, 2006-06-15 |
June, 2017 | FDA 483 | NEOLPHARMA, INC. - Form 483, 2017-06-07 |
March, 2003 | FDA 483 | Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - Form 483, 2003-03-13 |
June, 2017 | EIR | NEOLPHARMA, INC. - EIR, 2017-06-07 |
July, 2016 | FDA 483 | AbbVie Ltd - Form 483, 2016-07-29 |
March, 2009 | FDA 483 | Pfizer Pharmaceuticals LLC - Form 483, 2009-03-19 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more